153 related articles for article (PubMed ID: 15126514)
1. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study.
Todorova B; Kubaszek A; Pihlajamäki J; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
J Clin Endocrinol Metab; 2004 May; 89(5):2019-23. PubMed ID: 15126514
[TBL] [Abstract][Full Text] [Related]
2. The G-250A substitution in the promoter region of the hepatic lipase gene is associated with the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
Zacharova J; Todorova BR; Chiasson JL; Laakso M;
J Intern Med; 2005 Feb; 257(2):185-93. PubMed ID: 15656877
[TBL] [Abstract][Full Text] [Related]
3. Association of the -250G/A promoter polymorphism of the hepatic lipase gene with the risk of peripheral arterial disease in type 2 diabetic patients.
Valdivielso P; Ariza MJ; de la Vega-Román C; González-Alegre T; Rioja J; Ulzurrun E; González-Santos P
J Diabetes Complications; 2008; 22(4):273-7. PubMed ID: 18413186
[TBL] [Abstract][Full Text] [Related]
4. [Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease].
Wei M; Lu YS; Li PP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):219-22. PubMed ID: 19350521
[TBL] [Abstract][Full Text] [Related]
5. The -250G>A promoter variant in hepatic lipase associates with elevated fasting serum high-density lipoprotein cholesterol modulated by interaction with physical activity in a study of 16,156 Danish subjects.
Grarup N; Andreasen CH; Andersen MK; Albrechtsen A; Sandbaek A; Lauritzen T; Borch-Johnsen K; Jørgensen T; Schmitz O; Hansen T; Pedersen O
J Clin Endocrinol Metab; 2008 Jun; 93(6):2294-9. PubMed ID: 18364377
[TBL] [Abstract][Full Text] [Related]
6. The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity and LDL cholesterol: The KANWU Study.
Lindi V; Schwab U; Louheranta A; Vessby B; Hermansen K; Tapsell L; Riccardi G; Rivellese AA; Laakso M; Uusitupa MI;
Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):88-95. PubMed ID: 17327141
[TBL] [Abstract][Full Text] [Related]
7. Association of the Leu72Met polymorphism of the ghrelin gene with the risk of Type 2 diabetes in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study.
Mager U; Lindi V; Lindström J; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Laakso M; Pulkkinen L; Uusitupa M;
Diabet Med; 2006 Jun; 23(6):685-9. PubMed ID: 16759313
[TBL] [Abstract][Full Text] [Related]
8. Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome: The Finnish Diabetes Prevention Study.
Kilpeläinen TO; Lakka TA; Laaksonen DE; Mager U; Salopuro T; Kubaszek A; Todorova B; Laukkanen O; Lindström J; Eriksson JG; Hämäläinen H; Aunola S; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Laakso M; Uusitupa M;
Metabolism; 2008 Mar; 57(3):428-36. PubMed ID: 18249219
[TBL] [Abstract][Full Text] [Related]
9. Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.
Kubaszek A; Pihlajamäki J; Komarovski V; Lindi V; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
Diabetes; 2003 Jul; 52(7):1872-6. PubMed ID: 12829659
[TBL] [Abstract][Full Text] [Related]
10. Common polymorphisms in the genes regulating the early insulin signalling pathway: effects on weight change and the conversion from impaired glucose tolerance to Type 2 diabetes. The Finnish Diabetes Prevention Study.
Laukkanen O; Pihlajamäki J; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
Diabetologia; 2004 May; 47(5):871-7. PubMed ID: 15127203
[TBL] [Abstract][Full Text] [Related]
11. G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia.
Pihlajamäki J; Karjalainen L; Karhapää P; Vauhkonen I; Taskinen MR; Deeb SS; Laakso M
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1789-95. PubMed ID: 10894818
[TBL] [Abstract][Full Text] [Related]
12. Interaction between cholesteryl ester transfer protein and hepatic lipase encoding genes and the risk of type 2 diabetes: results from the Telde study.
López-Ríos L; Nóvoa FJ; Chirino R; Varillas F; Boronat-Cortés M; Wägner AM
PLoS One; 2011; 6(11):e27208. PubMed ID: 22073289
[TBL] [Abstract][Full Text] [Related]
13. Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes.
Kilpeläinen TO; Lakka TA; Laaksonen DE; Laukkanen O; Lindström J; Eriksson JG; Valle TT; Hämäläinen H; Aunola S; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
Physiol Genomics; 2007 Oct; 31(2):264-72. PubMed ID: 17636114
[TBL] [Abstract][Full Text] [Related]
14. Association of the G-250A promoter polymorphism in the hepatic lipase gene with the risk of type 2 diabetes mellitus.
Ou L; Yao L; Guo Y; Fan S
Ann Endocrinol (Paris); 2013 Feb; 74(1):45-8. PubMed ID: 23351562
[TBL] [Abstract][Full Text] [Related]
15. [The association study of the LIPC -250g/A polymorphism and high-carbohydrate/low-fat diet induced serum lipid and apolipoprotein concentration changes in healthy youth].
Hu MS; Li ZK; Fang DZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):727-30, 735. PubMed ID: 24325099
[TBL] [Abstract][Full Text] [Related]
16. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.
Nordman S; Ding B; Ostenson CG; Kärvestedt L; Brismar K; Efendic S; Gu HF
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):282-7. PubMed ID: 15926114
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study.
Laukkanen O; Pihlajamäki J; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
J Clin Endocrinol Metab; 2004 Dec; 89(12):6286-90. PubMed ID: 15579791
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.
Laukkanen O; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
Diabetes; 2005 Jul; 54(7):2256-60. PubMed ID: 15983230
[TBL] [Abstract][Full Text] [Related]
19. SNPs in PPARG associate with type 2 diabetes and interact with physical activity.
Kilpeläinen TO; Lakka TA; Laaksonen DE; Lindström J; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Lindi V; Tuomilehto J; Uusitupa M; Laakso M
Med Sci Sports Exerc; 2008 Jan; 40(1):25-33. PubMed ID: 18091023
[TBL] [Abstract][Full Text] [Related]
20. An igf-I gene polymorphism modifies the risk of diabetic retinopathy.
Rietveld I; Ikram MK; Vingerling JR; Hofman A; Pols HA; Lamberts SW; de Jong PT; van Duijn CM; Janssen JA
Diabetes; 2006 Aug; 55(8):2387-91. PubMed ID: 16873705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
